Outcome of patients with advanced lung adenocarcinoma treated with first-line epidermal growth factor receptor tyrosine kinase inhibitors versus cytotoxic chemotherapy
Background: There is no published data on the response and survival of Malaysian patients with locally advanced or metastatic adenocarcinoma of the lung with and without epidermal growth factor receptor (EGFR) mutations treated with EGFRtyrosine kinase inhibitors (TKIs) or cytotoxic chemotherapy. O...
Saved in:
Main Author: | Chai, Chee She |
---|---|
Format: | Thesis |
Language: | English |
Published: |
2015
|
Subjects: | |
Online Access: | http://ir.unimas.my/id/eprint/10817/1/Dr%20Chai%20Chee%20Shee%20ft.pdf |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Characteristics of epidermal growth factor receptor (EGFR)-mutated non small cell lung cancer (NSCLC) patients who developed resistance to first-or second-generation egfr-tyrosine kinase inhibitor (TKI) therapy through T790 mutation /
by: Vijayan Munusamy
Published: (2017) -
Regulation of myelomonocytic cell functions by inhibitors of the tyrosine kinase signaling cascade /
by: Li, Hui
Published: (2001) -
Expression of ron tyrosin kinase receptor on breast cancer cell lines
by: Alzeini, Khaled W. K.
Published: (2013) -
Epidermal growth factor receptor (EGFR) mutation in lung carcinoma /
by: Fatin Izni Nazri
Published: (2018) -
Adherence To Tyrosine Kinase Inhibitor Therapy Among Chronic Myeloid Leukemia Patients /
by: Wilfred, Gilbert
Published: (2015)